Study guide

5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis

Key Takeaways Explain This Topic AI

European acne guidance favours fixed combinations such as adapalene with benzoyl peroxide for papulopustular acne and oral isotretinoin for severe nodular or conglobate acne.

Oral antibiotics for acne should be combined with a topical retinoid or benzoyl peroxide and limited to about 3 months to reduce antimicrobial resistance.

Acne fulminans presents with painful ulcerating nodules and often fever, can be triggered by starting isotretinoin, and is treated with oral prednisolone and reduced or paused isotretinoin.

The ROSCO rosacea panel defines two diagnostic phenotypes, fixed centrofacial erythema with periodic intensification and phymatous change, and treats each feature separately.

Perioral dermatitis is strongly linked to topical corticosteroid use and is treated by stopping the steroid, with topical metronidazole or an oral tetracycline if needed.

Last updated: September 2026

5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis

These three conditions dominate facial dermatology. Questions often test the choice of first-line treatment, how to use antibiotics responsibly, and recognition of severe variants that need urgent systemic therapy.

  • Acne Vulgaris
  • Pathogenesis

Acne is a disease of the pilosebaceous unit with four main factors:

Increased sebum production driven by androgens (including local conversion by 5-alpha-reductase).

Follicular hyperkeratinisation , forming the microcomedo and then open (black) and closed (white) comedones.

Colonisation by Cutibacterium acnes (formerly Propionibacterium acnes ), which activates innate immunity through Toll-like receptor 2.

Inflammation , with IL-1 and other cytokines, producing papules, pustules, and nodules.

Diet (high glycaemic load and possibly dairy), and insulin-like growth factor 1 may contribute.

Clinical Forms and Variants

  • Form Features
  • Comedonal Open and closed comedones, little inflammation
  • Papulopustular Inflammatory papules and pustules, mild to moderate
  • Nodular / conglobate Deep nodules, sinus tracts, scarring; acne conglobata is the most severe chronic form

Acne fulminans Sudden painful ulcerating and haemorrhagic nodules, often with fever, arthralgia, and raised inflammatory markers; can follow the start of isotretinoin

  • Neonatal (cephalic pustulosis) Papulopustules in the first weeks, linked to Malassezia ; self-limiting
  • Infantile acne From 3 to 6 months; persistent or severe disease should prompt a check for hyperandrogenism

Drug-induced Monomorphic papulopustules without comedones: corticosteroids, androgens and anabolic steroids, lithium, isoniazid, halogens, EGFR inhibitors

Hormonal Adult women with lower-face acne; look for polycystic ovary syndrome (hirsutism, irregular periods)

Chloracne Comedones and cysts behind the ears and on the malar area after halogenated aromatic hydrocarbon (dioxin) exposure

  • Acne excoriée Picked lesions, often in young women; psychological factors
  • European Treatment Recommendations

European evidence-based guidance (EDF/EuroGuiDerm) grades treatment by acne type and severity:

  • Acne Type First-Choice Options
  • Comedonal Topical retinoid (adapalene, tretinoin) or azelaic acid

Mild-to-moderate papulopustular Fixed combination adapalene + benzoyl peroxide or clindamycin + benzoyl peroxide ; azelaic acid

Severe papulopustular / moderate nodular Oral isotretinoin , or an oral tetracycline (doxycycline, lymecycline) combined with adapalene or adapalene + benzoyl peroxide

Severe nodular / conglobate Oral isotretinoin ; if not possible, oral antibiotic plus topical combination

Antibiotic stewardship:

Do not use topical or oral antibiotics alone. Always combine them with benzoyl peroxide or a topical retinoid, which reduces resistance.

Limit oral antibiotic courses to about 3 months , then maintain with a topical retinoid.

Avoid using topical and oral antibiotics together.

Hormonal therapy: combined oral contraceptives can help women with acne. Those containing cyproterone acetate with ethinylestradiol are restricted in the EU to moderate-to-severe acne (and hirsutism) after topical treatment or antibiotics have failed, because of venous thromboembolism risk. Spironolactone is used off-label.

Isotretinoin reduces sebum, normalises keratinisation, and indirectly reduces C. acnes . Its dosing, monitoring, and EU Pregnancy Prevention Programme are covered in the oral retinoid section. For acne fulminans , start or continue oral prednisolone (about 0.5–1 mg/kg), pause or reduce isotretinoin, and reintroduce it at a low dose under steroid cover.

Scarring: atrophic (ice-pick, boxcar, rolling) and hypertrophic or keloid scars. Treat the acne early to prevent them. Established scars can be treated with lasers, chemical peels, microneedling, subcision, or fillers.

Rosacea

Rosacea is a chronic inflammatory disease of the central face, most often in fair-skinned adults. Triggers include heat, sunlight, alcohol, hot drinks, spicy food, and exercise. Neurovascular dysregulation, innate immune activation (cathelicidin), and Demodex mites are involved.

ROSCO Phenotype Approach

The global ROSacea COnsensus (ROSCO) panel replaced the older subtypes with phenotypes , each treated on its own merits:

Category Features

Diagnostic (one is enough) Fixed centrofacial erythema with periodic intensification; phymatous changes (for example rhinophyma)

Major (two or more suggest rosacea) Flushing or transient erythema; inflammatory papules and pustules; telangiectasia; ocular signs (lid margin telangiectasia, blepharitis, keratitis)

  • Minor Burning, stinging, oedema, dryness
  • Treatment by Feature

Persistent erythema: brimonidine gel (alpha-2 agonist) or oxymetazoline cream; vascular lasers and intense pulsed light.

Papules and pustules: ivermectin 1% cream , metronidazole, azelaic acid; for moderate-to-severe disease, oral doxycycline 40 mg modified-release (anti-inflammatory dose); low-dose isotretinoin (off-label) for refractory disease.

Telangiectasia: vascular laser (pulsed dye, KTP) or intense pulsed light.

Phyma: surgery, ablative laser, or electrosurgery; isotretinoin for early disease.

Ocular rosacea: lid hygiene and warm compresses, topical or oral doxycycline, and ophthalmology referral for keratitis.

General: gentle skincare, daily sun protection, and trigger avoidance.

Differentials: lupus erythematosus (no pustules, photosensitive), seborrhoeic dermatitis, acne (comedones), carcinoid flushing, and steroid-induced rosacea after facial corticosteroid use.

Perioral (Periorificial) Dermatitis

Who: mainly young women, also children.

Clinical: small red papules and pustules around the mouth, nose, and sometimes the eyes, with a clear rim of spared skin next to the lip vermilion.

Cause: strongly associated with topical corticosteroid use, also heavy cosmetics and fluoridated toothpaste.

Treatment: stop the topical steroid ("zero therapy"). Warn about a rebound flare. Use topical metronidazole, erythromycin, azelaic acid, or pimecrolimus; for extensive disease, an oral tetracycline for 6–8 weeks (erythromycin in young children).

Granulomatous periorificial dermatitis in children (including facial Afro-Caribbean childhood eruption) produces yellow-brown papules with granulomas on histology.